Form 8-K - Current report:
SEC Accession No. 0001558370-24-015311
Filing Date
2024-11-12
Accepted
2024-11-12 16:05:18
Documents
42
Period of Report
2024-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrns-20241112x8k.htm   iXBRL 8-K 46699
2 EX-99.1 mrns-20241112xex99d1.htm EX-99.1 238782
3 EX-99.2 mrns-20241112xex99d2.htm EX-99.2 44055
4 GRAPHIC mrns-20241112xex99d1001.jpg GRAPHIC 6714
5 GRAPHIC mrns-20241112xex99d2g001.jpg GRAPHIC 248724
6 GRAPHIC mrns-20241112xex99d2g002.jpg GRAPHIC 300099
7 GRAPHIC mrns-20241112xex99d2g003.jpg GRAPHIC 164677
8 GRAPHIC mrns-20241112xex99d2g004.jpg GRAPHIC 173483
9 GRAPHIC mrns-20241112xex99d2g005.jpg GRAPHIC 98198
10 GRAPHIC mrns-20241112xex99d2g006.jpg GRAPHIC 196094
11 GRAPHIC mrns-20241112xex99d2g007.jpg GRAPHIC 150605
12 GRAPHIC mrns-20241112xex99d2g008.jpg GRAPHIC 177451
13 GRAPHIC mrns-20241112xex99d2g009.jpg GRAPHIC 159633
14 GRAPHIC mrns-20241112xex99d2g010.jpg GRAPHIC 130656
15 GRAPHIC mrns-20241112xex99d2g011.jpg GRAPHIC 122616
16 GRAPHIC mrns-20241112xex99d2g012.jpg GRAPHIC 124980
17 GRAPHIC mrns-20241112xex99d2g013.jpg GRAPHIC 105415
18 GRAPHIC mrns-20241112xex99d2g014.jpg GRAPHIC 165719
19 GRAPHIC mrns-20241112xex99d2g015.jpg GRAPHIC 181792
20 GRAPHIC mrns-20241112xex99d2g016.jpg GRAPHIC 138919
21 GRAPHIC mrns-20241112xex99d2g017.jpg GRAPHIC 130774
22 GRAPHIC mrns-20241112xex99d2g018.jpg GRAPHIC 142134
23 GRAPHIC mrns-20241112xex99d2g019.jpg GRAPHIC 134893
24 GRAPHIC mrns-20241112xex99d2g020.jpg GRAPHIC 206622
25 GRAPHIC mrns-20241112xex99d2g021.jpg GRAPHIC 138266
26 GRAPHIC mrns-20241112xex99d2g022.jpg GRAPHIC 94017
27 GRAPHIC mrns-20241112xex99d2g023.jpg GRAPHIC 121095
28 GRAPHIC mrns-20241112xex99d2g024.jpg GRAPHIC 150057
29 GRAPHIC mrns-20241112xex99d2g025.jpg GRAPHIC 74264
30 GRAPHIC mrns-20241112xex99d2g026.jpg GRAPHIC 142502
  Complete submission text file 0001558370-24-015311.txt   5931476

Data Files

Seq Description Document Type Size
31 EX-101.SCH mrns-20241112.xsd EX-101.SCH 3255
32 EX-101.LAB mrns-20241112_lab.xml EX-101.LAB 16593
33 EX-101.PRE mrns-20241112_pre.xml EX-101.PRE 10715
44 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20241112x8k_htm.xml XML 5113
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 241447949
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)